58 related articles for article (PubMed ID: 12376962)
21. Endogenous virus and hepatitis C virus-like particle budding in BHK-21 cells.
Blanchard E; Brand D; Roingeard P
J Virol; 2003 Mar; 77(6):3888-9; author reply 3889. PubMed ID: 12610167
[No Abstract] [Full Text] [Related]
22. Antibody responses to the hepatitis C virus E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects.
Cerino A; Bissolati M; Cividini A; Nicosia A; Esumi M; Hayashi N; Mizuno K; Slobbe R; Oudshoorn P; Silini E; Asti M; Mondelli MU
J Med Virol; 1997 Jan; 51(1):1-5. PubMed ID: 8986942
[TBL] [Abstract][Full Text] [Related]
23. Characterization of hepatitis C virus structural proteins with a recombinant baculovirus expression system.
Hsu HH; Donets M; Greenberg HB; Feinstone SM
Hepatology; 1993 May; 17(5):763-71. PubMed ID: 8387945
[TBL] [Abstract][Full Text] [Related]
24. Expression and self-assembly of HCV structural proteins into virus-like particles and their immunogenicity.
Zhao W; Liao GY; Jiang YJ; Jiang SD
Chin Med J (Engl); 2004 Aug; 117(8):1217-22. PubMed ID: 15361298
[TBL] [Abstract][Full Text] [Related]
25. Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeast.
Martinez-Donato G; Acosta-Rivero N; Morales-Grillo J; Musacchio A; Vina A; Alvarez C; Figueroa N; Guerra I; Garcia J; Varas L; Muzio V; Dueñas-Carrera S
Biochem Biophys Res Commun; 2006 Apr; 342(2):625-31. PubMed ID: 16488393
[TBL] [Abstract][Full Text] [Related]
26. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
27. Recombinant hepatitis C virus-like particles expressed by baculovirus: utility in cell-binding and antibody detection assays.
Xiang J; Wünschmann S; George SL; Klinzman D; Schmidt WN; LaBrecque DR; Stapleton JT
J Med Virol; 2002 Dec; 68(4):537-43. PubMed ID: 12376962
[TBL] [Abstract][Full Text] [Related]
28. [Expression of hepatitis C virus genome].
Nishihara T; Mizuno K; Shikata T
Nihon Rinsho; 1993 Feb; 51(2):323-8. PubMed ID: 7681882
[TBL] [Abstract][Full Text] [Related]
29. [Antibodies generated against hepatitis C virus (HCV) core antigen: IgM and IgA antibody against HCV core].
Sato S; Fujiyama S; Chikazawa H; Tanaka M
Nihon Rinsho; 1995 Sep; 53 Suppl(Pt 1):253-9. PubMed ID: 7563714
[No Abstract] [Full Text] [Related]
30. Virus-like particle-based vaccines against hepatitis C virus infection.
Bellier B; Klatzmann D
Expert Rev Vaccines; 2013 Feb; 12(2):143-54. PubMed ID: 23414406
[TBL] [Abstract][Full Text] [Related]
31. [Searching for hepatitis C virus by immunoelectron microscopy and its morphology].
Watanabe S; Kaito M; Kohara K; Kohara M
Nihon Rinsho; 1995 Aug; 53(8):2069-78. PubMed ID: 7563652
[TBL] [Abstract][Full Text] [Related]
32. [Ultrastructural features of the HCV particle and HCV-like particles].
Watanabe S; Kaito M; Ishida S; Naoki F; Kohara M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):10-9. PubMed ID: 15359756
[No Abstract] [Full Text] [Related]
33. [The present studies of the development of HCV vaccine].
Takikawa S; Matsuura Y; Miyamura T
Nihon Rinsho; 2001 Jul; 59(7):1379-83. PubMed ID: 11494555
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
